Concentra Group Holdings Parent, Inc. - 10-Q Summary (Q2 2024)
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended June 30, 2024. Concentra is the largest provider of occupational health services in the United States, operating 547 occupational health centers and 154 onsite clinics across 42 states. Historically an operating segment of Select Medical Corporation, Concentra converted from an LLC to a Delaware corporation in March 2024. On July 26, 2024, subsequent to the reporting period, the Company completed its Initial Public Offering (IPO) and separated from Select Medical.
Key Financial Metrics
| Metric | Q2 2024 (3 Months) | Q2 2023 (3 Months) | YTD 2024 (6 Months) | YTD 2023 (6 Months) |
|---|---|---|---|---|
| Revenue | $477.9 million | $467.1 million | $945.5 million | $923.4 million |
| Net Income (Company) | $51.7 million | $52.7 million | $100.7 million | $99.0 million |
| Operating Income | $83.9 million | $82.1 million | $159.4 million | $157.4 million |
| Operating Margin | 17.6% | 17.6% | 16.9% | 17.0% |
| Adjusted EBITDA | $101.6 million | $100.4 million | $197.7 million | $194.1 million |
| Adjusted EBITDA Margin | 21.3% | 21.5% | 20.9% | 21.0% |
| Cash from Operations (YTD) | $115.1 million (2024) vs $99.5 million (2023) | |||
| Ending Cash Balance | $50.7 million (as of June 30, 2024) | |||
| Total Debt | $427.7 million (as of June 30, 2024) |
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased 2.3% in Q2 and 2.4% YTD compared to the prior year. This growth was driven primarily by a 3.9% increase in revenue per visit, offsetting a 1.6% decline in total patient visits.
- Visit Volume: Total visits per day (VPD) decreased 1.6% in Q2. Workers' compensation visits increased 1.8%, while employer services visits declined 4.4%.
- Cost Structure: Cost of services as a percentage of revenue increased slightly to 71.0% in Q2 (from 70.6% in 2023) and 71.5% YTD (from 71.3% in 2023), reflecting inflationary pressures on labor and supply costs.
- Interest Expense: Interest expense on related party debt decreased significantly ($9.3M in Q2 2024 vs $11.5M in Q2 2023) due to lower average outstanding borrowings from Select Medical.
- Equity in Losses: The Company recorded a $3.7 million equity loss in unconsolidated subsidiaries in Q2 2024 due to an impairment of an investment, compared to no such loss in the prior year.
Guidance, Outlook, and Risks
Outlook and Subsequent Events: The filing does not provide specific forward-looking financial guidance for the full year. However, it details the successful completion of the IPO on July 26, 2024, raising approximately $516.3 million in net proceeds. Concurrently, the Company established new credit facilities totaling $1.25 billion and issued $650 million in Senior Notes. Proceeds were used to repay the $420 million related-party revolving promissory note and pay a dividend to Select Medical.
Risks and Contingencies:
- Regulatory Investigations: The Company is cooperating with a U.S. Department of Justice (DOJ) investigation regarding physical therapy billing practices and a subpoena from the California Department of Insurance regarding billing and coding.
- Data Breach Litigation: Following a 2023 data breach at a third-party vendor (Perry Johnson & Associates), six putative class-action lawsuits were filed in early 2024. Management does not currently believe these will have a material impact but cannot predict outcomes.
- Operational Risks: Key risks include labor shortages, inflationary cost pressures, changes in state workers' compensation fee schedules, and the execution of the separation from Select Medical.
Investor Verification Checklist
- Post-IPO Capital Structure: Verify the final terms of the new $1.25 billion credit facility and $650 million Senior Notes issued in July 2024, as these replace the related-party debt shown in the balance sheet.
- Regulatory Exposure: Monitor the status of the DOJ investigation into physical therapy billing and the California Department of Insurance subpoena for potential fines or operational restrictions.
- Visit Volume Trends: Assess the sustainability of the decline in employer services visits (-4.4% in Q2) and whether revenue per visit increases can continue to offset volume declines.
- Separation Costs: Review the $1.6 million in separation transaction costs incurred YTD and estimate future one-time costs associated with becoming a standalone public entity.
- Related Party Transactions: Confirm the cessation of shared service fees and other allocations from Select Medical following the July 2024 separation.